期刊文献+

传染性脓疱病毒112基因的原核表达及亚细胞定位 被引量:3

Prokaryotic expression and subcellular localization of orf virus 112 gene
原文传递
导出
摘要 对本实验室分离的传染性脓疱病毒(ORFV)AH-F10株的112基因进行克隆、原核表达及亚细胞定位。通过PCR方法获得其112基因,并分别构建原核表达重组质粒pET-32a-112及真核表达重组质粒pEGFP-C3-112。pET-32a-112经IPTG诱导表达,获得112蛋白并制备超免疫血清。同时将pEGFP-C3-112转染BHK21细胞,观察病毒112蛋白的亚细胞定位。结果显示,pET-32a-112在大肠杆菌中主要以包涵体形式表达,大小约为60 ku;Western-blot结果表明,重组112蛋白具有良好的反应原性;112蛋白主要定位于细胞质中。本试验为进一步研究112蛋白的功能奠定了一定的理论基础。 This study was designed to prokaryotically express and subcellularly localize the 112 gene of the ORFV AH-F10 strain.At first,112 gene was amplified by PCR.Then, the prokaryotic and eukaryotic expression recombinant plasmids named pET-32 a-112 and pEGFP-C3-112 were successfully constructed.Subsequently,112 recombinant proteins were acquired by induction with IPTG.The expressed protein was purified and immunized with BALB/c mice to prepare for antiserum.The pEGFP-C3-112 was transfected into BHK-21 cells by Lipofectamine 2 000.Then,the subcellular localization of the expressed 112 protein was observed by inverted fluorescence microscopy.The results showed that pET-32 a-112 was successfully expressed in the form of inclusion bodies in E.coli with a size of about 60 ku.The results of Western-blot demonstrated that the expressed 112 protein had good reactionogenicity with the antiserum.The results of subcellular localization showed that the 112 protein was mainly located in the cytoplasm.The present study laid a theoretical foundation for further study of thefunction of 112 protein.
出处 《中国兽医科学》 CAS CSCD 北大核心 2017年第10期1275-1280,共6页 Chinese Veterinary Science
基金 国家自然科学基金项目(31602063) 安徽省自然科学基金项目(1508085QC60) 安徽农业大学稳定和引进人才科研资助项目(yj2015-16) 安徽农业大学大学生科技创新基金项目
关键词 传染性脓疱病毒 112基因 原核表达 亚细胞定位 orf virus 112 gene prokaryotic expression subcellular localization
  • 相关文献

参考文献10

二级参考文献180

  • 1杨海波,孟庆玲,乔军,才学鹏,贺志昊,刘昱成,彭叶龙,王国超,陈创夫,都曼.努尔坎杰.羊口疮病毒新疆流行株的分离鉴定及其遗传进化分析[J].西北农林科技大学学报(自然科学版),2015,43(2):14-22. 被引量:11
  • 2杜宇,樊明文,李宇红,郭继华,边专,陈智.防龋DNA疫苗pGJA-P/VAX免疫小鼠后的抗DNA抗体检测[J].口腔医学研究,2006,22(5):465-467. 被引量:9
  • 3[1]Yoshie O, Imai T, Nomiyama H. Chemokines in immunity[J]. Adv Immunol, 2001,78:57-110.
  • 4[2]Cascieri MA, Springer MS. The chemokine/chemokine-receptor family: potential and progress for therapeutic interven-tion[J]. Curr Opin Chem Bio,2000,4(4):420-427.
  • 5[3]Christopherson K 2nd, Hromas R. Chemokine regulation of normal and pathologic immune responses[J]. Stem Cells,2001,19(5):388-396.
  • 6[4]Murphy PM, Baggiolini M, Charo IF. International union of pharmacology. XXII. Nomenclature for chemokine receptors[J]. Pharmacol Rev,2000,52(1): 145-176.
  • 7[5]Fernandez EJ, Lolis E. Structure, function, and inhibition of chemokines[J]. Annu Rev Pharmacol Toxicol,2002,42:469-499.
  • 8[6]Luo J, Luo Z, Zhou N, et al. Attachment of C-terminus of SDF-1 enhances the biological activity of its N-terminal peptide[J]. Bioch Biophy Res Communicat,1999,264(1):42-47.
  • 9[7]Amara A, Lorthioir O, Valenzuela A, et al. SDF-1( associates with heparin sulfates through the first β-strand of the chemokine[J]. J Bio Chem,1999,274(34):23 916-23 925.
  • 10[8]Campbell JJ,Butcher EC. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing[J]. Cur Opin Immunol,2000,12(3):336-341.

共引文献132

同被引文献19

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部